Dorothy Cash
Family · Panama City, FLNPI 1871013441
Payments from drug & device makers
Across 219 payments — averaging $27.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- GSK$1K
- AstraZeneca$958
- Boehringer Ingelheim$294
- Sanofi$193
- Insmed, Inc.$143
- plus $375 from 12 others
What the payments were for
- Travel & lodging$1,75330%
- Food & beverage$4,17270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 29 | $2,563 |
| GSK | 94 | $1,399 |
| AstraZeneca | 49 | $958 |
| Boehringer Ingelheim | 15 | $294 |
| Sanofi | 7 | $193 |
| Insmed, Inc. | 6 | $143 |
| Mylan Specialty L.p. | 4 | $95 |
| Verona Pharma, Inc. | 3 | $55 |
| Grifols USA, LLC | 3 | $47 |
| Viatris Specialty LLC | 1 | $28 |
| Philips North America LLC | 1 | $24 |
| Harmony Biosciences LLC | 1 | $24 |
| Amgen | 1 | $22 |
| 3b Medical, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Olympus America Inc. | 1 | $16 |
| Fisher & Paykel Healthcare Inc | 1 | $15 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,874
How this compares
$5,925 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 225 | $239,524 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 71 | $61,233 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 42 | $27,511 |
| Breo ElliptaFluticasone/Vilanterol | 36 | $21,960 |
| Spiriva RespimatTiotropium Bromide | 17 | $16,004 |
| SymbicortBudesonide/Formoterol Fumarate | 32 | $15,377 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 239 | $11,658 |
| Incruse ElliptaUmeclidinium Bromide | 13 | $7,008 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 30 | $5,436 |
| Ventolin HfaAlbuterol Sulfate | 37 | $3,330 |
| Wixela InhubFluticasone Propion/Salmeterol | 15 | $1,362 |
| Montelukast Sodium | 80 | $714 |
| Doxycycline Hyclate | 34 | $299 |
| Prednisone | 36 | $109 |
| Azithromycin | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $1,399 | $296,002316 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $958 | $76,610103 claims |
| Boehringer IngelheimSpiriva Respimat | $294 | $16,00417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Panama City
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.